The Board denied the Veteran's claims for service connection for multiple myeloma and soft tissue sarcoma, finding no evidence of these conditions during or approximate to the pendency of the claim.
The deciding factor: There was no current diagnosis of multiple myeloma or soft tissue sarcoma as evidenced by post-service VA and private treatment records and a May 2023 VA examination.
- Claimed conditions
- multiple myeloma, soft tissue sarcoma
- How they argued it
- Direct service connection
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- November 10, 2025
- Citation
- A25097619
Veterans Law Judge
Decisions by this judge: 916 · Granted: 40% (granted or partly granted, in the vetted decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A25097619.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Veteran's claim for an initial rating in excess of 100 percent for service-connected multiple myeloma has been denied. The Board also remanded two issues related to nerve neuropathies, and the claims for TDIU and SMC have been denied.
- Remanded (sent back)
The Board has remanded the claims for service connection for multiple myeloma and back problems due to a duty to assist error. For multiple myeloma, the Veteran's exposure to asbestos is not verified. For back problems, an addendum opinion is needed to consider the Veteran's lay statements regarding her training-related injuries.
- Granted
The Board has granted service connection for multiple myeloma, finding that the evidence is in equipoise and resolving all reasonable doubt in favor of the appellant.
- Granted
The Board has granted service connection for multiple myeloma, diabetes mellitus II, and coronary artery disease (CAD) based on the Veteran's in-service exposure to herbicide agents.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.